These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 22414679)
21. Synthesis, structural characterization and biological evaluation of novel [1,2,4]triazolo [1,5-b][1,2,4]benzothiadiazine-benzothiazole conjugates as potential anticancer agents. Kamal A; Khan MN; Reddy KS; Srikanth YV; Sridhar B Chem Biol Drug Des; 2008 Jan; 71(1):78-86. PubMed ID: 18086151 [TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of disubstituted (4-piperidinyl)-piperazine derivatives as potent acetyl-CoA carboxylase inhibitors. Chonan T; Tanaka H; Yamamoto D; Yashiro M; Oi T; Wakasugi D; Ohoka-Sugita A; Io F; Koretsune H; Hiratate A Bioorg Med Chem Lett; 2010 Jul; 20(13):3965-8. PubMed ID: 20537533 [TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of novel nitroaromatic compounds as potent glutathione reductase inhibitors. Çakmak R; Durdagi S; Ekinci D; Sentürk M; Topal G Bioorg Med Chem Lett; 2011 Sep; 21(18):5398-402. PubMed ID: 21795044 [TBL] [Abstract][Full Text] [Related]
24. A structure-activity relationship study of 1,2,4-triazolo[1,5-a][1,3,5]triazin-5,7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities. Bera H; Tan BJ; Sun L; Dolzhenko AV; Chui WK; Chiu GN Eur J Med Chem; 2013 Sep; 67():325-34. PubMed ID: 23871912 [TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors. Paquin I; Raeppel S; Leit S; Gaudette F; Zhou N; Moradei O; Saavedra O; Bernstein N; Raeppel F; Bouchain G; Fréchette S; Woo SH; Vaisburg A; Fournel M; Kalita A; Robert MF; Lu A; Trachy-Bourget MC; Yan PT; Liu J; Rahil J; MacLeod AR; Besterman JM; Li Z; Delorme D Bioorg Med Chem Lett; 2008 Feb; 18(3):1067-71. PubMed ID: 18160287 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and anticancer activity of novel 2-amino-4-(4-phenylpiperazino)- 1,3,5-triazine derivatives. Pomarnacka E; Bednarski P; Grunert R; Reszka P Acta Pol Pharm; 2004; 61(6):461-6. PubMed ID: 15794339 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives. Saczewski F; Bułakowska A Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910 [TBL] [Abstract][Full Text] [Related]
29. Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase. Tang H; Wei YB; Zhang C; Ning FX; Qiao W; Huang SL; Ma L; Huang ZS; Gu LQ Eur J Med Chem; 2009 Jun; 44(6):2523-32. PubMed ID: 19243862 [TBL] [Abstract][Full Text] [Related]
30. Regioselective synthesis of 5- and 6-methoxybenzimidazole-1,3,5-triazines as inhibitors of phosphoinositide 3-kinase. Miller MS; Pinson JA; Zheng Z; Jennings IG; Thompson PE Bioorg Med Chem Lett; 2013 Feb; 23(3):802-5. PubMed ID: 23265896 [TBL] [Abstract][Full Text] [Related]
31. O-linked triazolotriazines: potent and selective c-Met inhibitors. Chen F; Wang Y; Ai J; Zhan Z; Lv Y; Liang Z; Luo C; Mei D; Geng M; Duan W ChemMedChem; 2012 Jul; 7(7):1276-85. PubMed ID: 22539497 [TBL] [Abstract][Full Text] [Related]
32. Stereoselective synthesis of bioactive isosteviol derivatives as alpha-glucosidase inhibitors. Wu Y; Yang JH; Dai GF; Liu CJ; Tian GQ; Ma WY; Tao JC Bioorg Med Chem; 2009 Feb; 17(4):1464-73. PubMed ID: 19167896 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of 3-(carboxyarylalkyl)imidazo[2,1-f][1,2,4]triazines as potential inhibitors of AMP deaminase. Kirkman JK; Lindell SD; Maechling S; Slawin AM; Moody CJ Org Biomol Chem; 2008 Dec; 6(23):4452-9. PubMed ID: 19005607 [TBL] [Abstract][Full Text] [Related]
35. Structure basis for the inhibitory mechanism of a novel DNase gamma-specific inhibitor, DR396. Sunaga S; Yoshimori A; Shiokawa D; Tanuma S Bioorg Med Chem; 2006 Jun; 14(12):4217-26. PubMed ID: 16574417 [TBL] [Abstract][Full Text] [Related]
36. Discovery of mixed type thymidine phosphorylase inhibitors endowed with antiangiogenic properties: synthesis, pharmacological evaluation and molecular docking study of 2-thioxo-pyrazolo[1,5-a][1,3,5]triazin-4-ones. Part II. Bera H; Ojha Pk; Tan BJ; Sun L; Dolzhenko AV; Chui WK; Chiu GN Eur J Med Chem; 2014 May; 78():294-303. PubMed ID: 24686016 [TBL] [Abstract][Full Text] [Related]
37. One-pot synthesis of fluorescent 2,5-dihydro-1,2,3-triazine derivatives from a cascade rearrangement sequence in the reactions of 1,2,3-triazolium-1-aminide 1,3-dipoles with propiolate esters. Butler RN; Fahy AM; Fox A; Stephens JC; McArdle P; Cunningham D; Ryder A J Org Chem; 2006 Jul; 71(15):5679-87. PubMed ID: 16839149 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of some novel 6-benzyl(or substituted benzyl)-2-beta-D-glucopyranosyl-1,2,4-triazolo[4,3-b][1,2,4]triazines as potential antimicrobial chemotherapeutics. Khalil NS; Mansour AK; Eid MM Nucleosides Nucleotides Nucleic Acids; 2004; 23(12):1889-910. PubMed ID: 15628747 [TBL] [Abstract][Full Text] [Related]